Q0114 – Fern test
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ0114
- Long description
- Fern test
- Short description
- Fern test
- Pricing indicator
21Clinical Lab Fee Schedule – national limitation amount- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
T1HLab tests - other (Non-Medicare fee schedule)- Added
- January 1, 1994
- Last change
- January 1, 2020 – No change
Frequently asked questions
What is HCPCS code Q0114?
Q0114 is a HCPCS Level II code for fern test.
Does Medicare cover Q0114?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q0083 – Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
- Q0084 – Chemotherapy administration by infusion technique only, per visit
- Q0085 – Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
- Q0091 – Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
- Q0092 – Set-up portable x-ray equipment
- Q0111 – Wet mounts, including preparations of vaginal, cervical or skin specimens
- Q0112 – All potassium hydroxide (koh) preparations
- Q0113 – Pinworm examinations
- Q0115 – Post-coital direct, qualitative examinations of vaginal or cervical mucous
- Q0138 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
- Q0139 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
- Q0144 – Azithromycin dihydrate, oral, capsules/powder, 1 gram
- Q0155 – Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0161 – Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0162 – Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0163 – Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.